Dr Hannah Wardill

Dr Hannah Wardill is a Hospital Research Foundation Fellow and lead of the Supportive Oncology Research Group (SORG), in the School of Biomedicine, University of Adelaide and Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute (SAHMRI). She is an Executive Board Member of the Multinational Association for Supportive Care in Cancer / International Society for Oral Oncology (MASCC/ISOO) and Chair of both MASCC/ISOO Patient Partnership Committee & the Palliative Care Clinical Studies Collaborative (PaCCSC) Cancer Symptom Trials (Gut Dysfunction Node; supported by Cancer Australia).

While her research started in understanding how chemotherapy damages gut health, Dr Wardill’s research program has now expanded to include a range of symptoms and side effects including neuropathy, cognitive impairment, infection and malnutrition.

A fierce advocate for supportive cancer care, Dr Wardill is working to improve the visibility of this research area and remind people that optimal cancer control can (and should) involve high quality, evidence-based supportive care to ensure people living with or beyond cancer can live happy and fulfilling lives.